If you would like further information, please ask any of the staff at the clinic. They will be happy to help.

Similar documents
Photodynamic Therapy (PDT) for agerelated

Photodynamic therapy (PDT) for Central Serous Retinopathy (CSR)/ Polypoidal Choroidal Vasculopathy (PCV)

Treatment of Age Related Macular Degeneration (AMD) by Intravitreal Injection

Age-Related Macular Degeneration (AMD)

Ophthamology Directorate. Eye Injection for Macular Disorders Information for Patients

Age-Related. macular degeneration.

Preparing for laser treatment for diabetic retinopathy and maculopathy

Treatment of wet macular degeneration by intravitreal injection with Ranibizumab (Lucentis) or Aflibercept (Eylea): Information and consent

Photofrin 75 mg Powder for solution for injection Porfimer sodium

Diabetes & Your Eyes

Treatment of Retinal Vein Occlusion (RVO)

What is Age-Related Macular Degeneration?

Age-related Macular Degeneration (AMD) treatment information

Patient Information Cataract Surgery

Important: Please read before your appointment

The Human Eye. Cornea Iris. Pupil. Lens. Retina

Intravitreal Injection

INFORMED CONSENT FOR AVASTIN TM (BEVACIZUMAB) INTRAVITREAL INJECTION

GENERAL INFORMATION DIABETIC EYE DISEASE

Treatment of Diabetic Macular Oedema by Intravitreal Injection with Ranibizumab (Lucentis)

In all cases, a doctor will explain the procedure to you and answer any questions you may have.

VISIONCARE S IMPLANTABLE MINIATURE TELESCOPE (by Dr. Isaac Lipshitz)

Package leaflet: Information for the user. Visudyne 15 mg powder for solution for infusion verteporfin

Diabetic Retinopathy Information

Patient Information Fundus fluorescein angiography

Patient information. Retinal Detachment Surgery St. Paul s Eye Unit PIF 024 V7

Diabetic retinopathy damage to the blood vessels in the retina. Cataract clouding of the eye s lens. Cataracts develop at an earlier age in people

Brampton Hurontario Street Brampton, ON L6Y 0P6

Patient Information Argon macular laser treatment Introduction

Diabetic Retinopathy WHAT IS DIABETIC RETINOPATHY? WHAT CAUSES DIABETIC RETINOPATHY? WHAT ARE THE STAGES OF DIABETIC RETINOPATHY?

Age-related macular degeneration (AMD) and RANIBIZUMAB (Lucentis)

Cataract and Cataract Surgery

Introduction How the eye works

Uveitis / Iritis. Introduction. Other formats

GHPI0100_06_10 Contact: Ophthalmology Review due: June What is a Cataract?

Caregiver s guide to wet AMD

Diabetic Retinopathy A Presentation for the Public

Information for patients considering cataract surgery Castleton Day Surgery Unit, Yeatman Hospital, Sherborne

Diabetic Eye Disease

Asymptomatic retinal detachment

Trabeculectomy (Glaucoma Drainage) Surgery

Cataracts in babies and children

Glaucoma Drainage Tube Surgery

Facts About Diabetic Eye Disease

PROOF. Intravenous Adult Community Therapy Team (IV-ACT Team) Intravenous antibiotics in the community

Information for Patients undergoing Intravitreal Triamcinolone Acetonide (Kenalog) Injection

The Foundation WHAT IS THE RETINA?

RETINAL CONDITIONS RETINAL CONDITIONS

Don t lose sight of the ones you love

A Patient s Guide to Diabetic Retinopathy

UVEITIS IN GENERAL. Information for patients UVEITIS CLINIC WHAT IS UVEITIS? MAIN CATEGORIES OF UVEITIS

RETINAL LASER SURGERY OR ARGON PHOTOCOAGULATION

Information for patients

Cataract Surgery. Patient Information. How your care will be organised. Introduction

Understanding Diabetic Retinopathy

eye conditions related to diabetes

AgePage. Aging And Your Eyes. Steps To Protect Your Eyesight

Fundus Fluorescein Angiography Indocyanine Green Angiography

MANAGING DIABETIC RETINOPATHY. <Your Hospital Name> <Your Logo>

Frequently Asked Questions About Photopheresis

Patient & Family Guide. Diabetes and the Eye. Aussi disponible en français : Le diabète et les yeux (FF )

OAKLEIGH EYE CENTRE. THE EYE Before looking at diabetic retinopathy it is important to understand what the healthy eye looks like and how it works.

Cataract Surgery: Information for patients. Back of eye. Vitreous. Retina. Lens

Screening for Uveitis in Children

Glaucoma Surgery Trabeculectomy

Myopia and pathological myopia. Fundus Photo, Right Eye (OD)

Selective Laser Trabeculoplasty (SLT)

Information for Patients. Deep sclerectomy for the treatment of Glaucoma

A patient s guide to treatment with Visudyne (verteporfin for injection)

Chemotherapy and the risk of extravasation

Information for Patients. Macular Hole

Fluorescein and Indocyanine Angiogram

Stabilisation of the shoulder joint

Diabetic Retinopathy. What should know

LASIK. Lens. Cornea. Iris. Vitreous. Macula. Retina

Epiretinal membrane. What is an epiretinal membrane?

NHS Diabetic Eye Screening Programme

Diabetic Retinopathy Frequently Asked Questions

Wedge incision of an ingrowing toenail

Retinal detachment. What is retinal detachment?

MAGNITUDE OF DIABETIC EYE DISEASE IN INDIA

DIABETIC RETINOPATHY

The Leeds Teaching Hospitals NHS Trust Catheter directed thrombolysis and pelvic venous stenting for ilio-femoral DVT

Ophthalmology. Cataract

Information for patients. Epiretinal Membrane. Royal Hallamshire Hospital

Trabeculectomy a treatment of Glaucoma

Information for Patients. Vitrectomy

UNDERSTAND MORE ABOUT UVEITIS UVEITIS

Laser Trans Urethral Resection of Prostate (TURP)

Oral PUVA Phototherapy

Maricopa Unified School District Health Services Heat Index Guidelines

PATIENT STUDY INFORMATION LEAFLET

Diabetic Retinopathy Screening Programme

About your fistula for dialysis. Information for patients Sheffield Kidney Institute (Renal Unit)

Arthroscopic shoulder stabilisation surgery

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM OZURDEX, dexamethasone 700 μg intravitreal implant

Intravitreal Injections for Wet Age Related Macular Degeneration

EYLEA. (aflibercept solution for injection) Patient Guide

Patient Information Brochure. Cataract

Corneal transplant surgery. Brought to you in association with EIDO Healthcare and endorsed by the Royal College of Surgeons England.

Transcription:

Photodynamic Therapy Patient Information Ninewells Hospital The aim of this leaflet is to give you some information about Photodynamic Therapy. It contains some useful information on what you can expect during treatment as well as some advice on what you should do before and after treatment. If you would like further information, please ask any of the staff at the clinic. They will be happy to help. What is Photodynamic Therapy (PDT)? Photodynamic Therapy is a treatment for the wet (neovascular) form of agerelated macular degeneration (AMD). It is a combination of: A photosensitive (light-activated) drug called Visudyne A red light produced by a non-thermal laser What does PDT do? The aim of PDT is to reduce the potential for loss of central vision caused by a type of AMD called wet AMD. Visudyne works by destroying abnormal blood vessels that grow behind the retina at the back of your eye. These abnormal vessels leak and bleed, leading to deterioration of the macula. Unlike other treatments for wet AMD, Visudyne therapy uses a non-thermal laser; the light produced by this type of laser does not burn the retina. In the majority of patients, the therapy initially slows down the loss of sight experienced by patients with wet AMD. Thereafter, the majority of patients experience stabilisation of their vision. What should you do to prepare for your therapy? The Visudyne therapy will cause your skin and eyes to become more sensitive to light. Therefore, you must avoid direct sunlight and bright lights for 48 hours after treatment. Page 1 of 5

To reduce this sensitivity please bring (or wear) the following items to the eye clinic: Wide brimmed hat and dark sunglasses Suitable footwear Clothing that will fully cover your skin What happens during PDT? You will be given an infusion (slow injection) of the light-activated drug called Visudyne into a vein in your arm. This lasts for ten minutes. If you have had a severe reaction to previous intravenous injections or if you have a strong allergic history, bring this to the attention of your eye doctor. Your eye specialist will then numb your eye with eyedrops and place a special contact lens on your eye. Shortly after this, a red light will be directed through the contact lens and onto the affected area of the retina. The light is applied for exactly 83 seconds. Because a non-thermal laser produces the red light there is no heating or burning. At the end of the treatment you will be given a green bracelet to wear for 48 hours. This is a precaution and is intended to remind you and other health care professionals that you have received Visudyne and undergone PDT. What are the side effects of PDT? All treatments have a risk and some patients experience adverse reactions to PDT these include: Injection site reactions such as pain, swelling, inflammation, leakage into the area surrounding the vein, bleeding at the site and hypersensitivity. Blurred vision and other visual disturbances. Back pain during infusion (around 2.2% of patients report back pain). Severe vision decrease (occurs in 1% - 4% of patients). Page 2 of 5

Please speak to your eye specialist if you experience any of these effects after therapy. What should you do following PDT? Visudyne will cause your skin and eyes to become more sensitive to light. Therefore you must avoid direct sunlight and bright lights for 48 hours immediately after treatment. Bright lights include but are not limited to: Stay away from undraped windows or skylights for 48 hours and do not rely on UV sunscreens to protect against photosensitivity; they will not be effective. Halogen lighting in homes and offices, including bright halogen lamps and reading lamps. After PDT you may have some vision problems. If this happens, you should not drive or use machinery until your vision improves. Can I go outside? If you do go out during daylight hours within the first 48 hours following treatment, it is important that you wear: Wide brimmed hat Dark sunglasses Long sleeved shirt and trousers Socks and shoes After 48 hours, you may resume normal outdoor activities without any special precautions. Page 3 of 5

You should not stay in the dark. In fact, exposing your skin to indoor light helps to inactivate any remaining drug in the skin. You may have some blurring of vision in the 48 hours following treatment, but this is usually short lived. Further appointments PDT normally involves more than one treatment to permanently close the leaking blood vessels. Your eye doctor will normally ask you to come back to the clinic every three months to assess your eyes. He/she will usually check your vision, take some pictures of your eye and carry out a dye test (fluorescein angiography) to determine if another treatment would be beneficial. You can expect to receive further treatment as your doctor feels necessary. Important Information Please carry this leaflet with you in case of an emergency. Name of Ophthalmologist: Dr P Johnstone / Dr J Vallance Eye Department Nurses contact number: Telephone: 01382 632993 Additional Information: Macular Disease Society Helpline: 0845 241 2041 www.maculardisease.org RNIB: Helpline: 0845 766 9999 www.rnib.org.uk Page 4 of 5

Contact numbers: Ninewells Hospital Eye Outpatient Department Telephone: 01382 633871 Eye Outpatient Nurses Telephone: 01382 632993 Clinic opening times: Monday Thursday, 8.30am 5pm Friday, 8.30am 2pm Ward 25 24 hours, 7 days a week Telephone: 01382 33825 Developed by medical and nursing staff and has been reviewed by patients Reviewed: 01/2018 Review: 01/2020 LN1026 Page 5 of 5